首页> 外文OA文献 >Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

【2h】

Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

机译：直接作用抗病毒药虫/ paritabrevir / ritonavir + dasabuvir在丙啶病毒（hcv）基因虫中（hcv）基因型1-感染的治疗 - 幼稚或治疗 - 经验丰富的患者或没有肝硬化的患者：立陶宛和拉脱维亚的现实生活经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ligita Jancoriene; Katazyna Polubenko; Edita Kazenaite; Arida Buivydiene; Jolita Jakutiene; Ieva Tolmane; Agita Jeruma; Daiva Radzisauskiene; Evelina Mockiene; Arvydas Ambrozaitis;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia [J] . Ligita Jancoriene, Katazyna Polubenko, Edita Kazenaite, Hepatitis Monthly . 2018,第1期

机译：直接作用抗病毒药物Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir联合或不联合利巴韦林在C型肝炎病毒（HCV）基因型1中感染的未接受过治疗或有治疗经验的患者是否患有肝硬化：立陶宛和拉脱维亚的真实生活
2. Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial [J] . Hezode Christophe, Asselah Tarik, Reddy K. Rajender, The Lancet . 2015,第9986期

机译：Ombitasvir + paritaprevir + ritonavir联合利巴韦林或不联合利巴韦林用于初治和有治疗经验的基因型4型慢性丙型肝炎病毒感染（PEARL-I）的患者：一项随机，开放标签的试验
3. Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy [J] . Poordad Fred, Bennett Michael, Sepe Thomas E., Journal of Medical Virology . 2019,第7期

机译：对于乙型肝炎病毒基因型1感染的患者，有或没有Sofosbuvir的蛋白质vir / paritaprevir / ritonavir和dasbuvir
4. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
5. Safety and Efficacy of Ombitasvir Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2 [O] . Jürgen K Rockstroh, Chloe Orkin, Rolando M Viani, 2017

机译：OmbitasvirParitaprevir与Ritonavir±Dasabuvir联合或不联合Ribavirin在人类免疫缺陷病毒-1和丙型肝炎病毒基因型1或基因型4合并感染的患者中的安全性和有效性：TURQUOISE-I第2部分
6. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis [O] . Fred Poordad, Shahriar Sedghi, Paul J. Pockros, 2019

机译：慢性丙基肝炎病毒基因型1A感染患者慢性丙基肝炎病毒基因型1A感染的疗效和Dasabuvir和Dasbuvir的疗效和安全性

Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

著录项

相似文献

相关主题

期刊订阅